Galera Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
04 May 2026	Form 3: Emerald Bioventures, Llc, 10% owner and 1 other Holds 40,216,160 shares of Common Stock
02 Jan 2025	Form 3: Chang Nancy T, Director No securities owned
02 Jan 2025	Form 3: Friedman Michael R., Director No securities owned
16 May 2024	Form 3: Soffer Rochel, 10% owner and 1 other Holds 3,178,137 shares of Common Stock
16 Jan 2024	Form 3: Schneid Yair, 10% owner Holds 7,110,801 shares of Common Stock
13 Nov 2023	Form 3: Altamont Pharmaceutical Holdings, Llc, 10% owner and 1 other Holds 5,280,000 shares of Common Stock
02 Sep 2022	Form 3: Kennedy Eugene P., Chief Medical Officer No securities owned
12 Oct 2021	Form 3: Bachleda Mark, Chief Commercial Officer No securities owned
12 Oct 2021	Form 3: Stacey Jennifer Evans, See Remarks No securities owned
02 Apr 2020	Form 3: West Linda, Director No securities owned
06 Nov 2019	Form 3: Blackstone Clarus Gp L.p., 10% owner and 6 others
06 Nov 2019	Form 3: Cunningham Emmett, Director No securities owned
06 Nov 2019	Form 3: Clarus IV-A, L.p., 10% owner and 4 others
06 Nov 2019	Form 3: Holmlund Jon T, Chief Medical Officer
06 Nov 2019	Form 3: Wood Brian, 10% owner
06 Nov 2019	Form 3: Brill Jeffrey, 10% owner
06 Nov 2019	Form 3: Alleva Lawrence M, Director
06 Nov 2019	Form 3: Beardsley Robert A, Chief Operating Officer Holds 52,830 shares of Common Stock
06 Nov 2019	Form 3: Buckler Regina A., 10% owner Holds 54,258 shares of Common Stock
06 Nov 2019	Form 3: Keene Jeffrey, 10% owner Holds 54,258 shares of Common Stock

Comments